A partial differential equation model of metastasized prostatic cancer

Avner Friedman, Harsh Vardhan Jain

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Biochemically failing metastatic prostate cancer is typically treated with androgen ablation. However, due to the emergence of castration-resistant cells that can survive in low androgen concentrations, such therapy eventually fails. Here, we develop a partial differential equation model of the growth and response to treatment of prostate cancer that has metastasized to the bone. Existence and uniqueness results are derived for the resulting free boundary problem. In particular, existence and uniqueness of solutions for all time are proven for the radially symmetric case. Finally, numerical simulations of a tumor growing in 2-dimensions with radial symmetry are carried in order to evaluate the therapeutic potential of different treatment strategies. These simulations are able to reproduce a variety of clinically observed responses to treatment, and suggest treatment strategies that may result in tumor remission, underscoring our model's potential to make a significant contribution in the field of prostate cancer therapeutics.

Original languageEnglish (US)
Pages (from-to)591-608
Number of pages18
JournalMathematical Biosciences and Engineering
Issue number3
StatePublished - Jun 2013
Externally publishedYes


  • Androgen ablation
  • Free boundary problem
  • Mathematical model
  • Prostate cancer
  • PSA


Dive into the research topics of 'A partial differential equation model of metastasized prostatic cancer'. Together they form a unique fingerprint.

Cite this